

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 5.78308049 |
| 2 | actin-mediated cell contraction (GO:0070252) | 5.49986087 |
| 3 | regulation of skeletal muscle contraction (GO:0014819) | 4.93707093 |
| 4 | melanin biosynthetic process (GO:0042438) | 4.90351744 |
| 5 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.80757237 |
| 6 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.76643317 |
| 7 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 4.68050004 |
| 8 | melanin metabolic process (GO:0006582) | 4.45323072 |
| 9 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.41455285 |
| 10 | cell communication by electrical coupling (GO:0010644) | 4.40098914 |
| 11 | tricarboxylic acid cycle (GO:0006099) | 4.39016014 |
| 12 | actomyosin structure organization (GO:0031032) | 4.28204262 |
| 13 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.24791720 |
| 14 | secondary metabolite biosynthetic process (GO:0044550) | 4.21170431 |
| 15 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 4.05571529 |
| 16 | actin filament-based movement (GO:0030048) | 4.02485065 |
| 17 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.01995007 |
| 18 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.95293687 |
| 19 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.93247922 |
| 20 | cell communication involved in cardiac conduction (GO:0086065) | 3.91300994 |
| 21 | cardiac myofibril assembly (GO:0055003) | 3.90805993 |
| 22 | fatty acid transmembrane transport (GO:1902001) | 3.86135238 |
| 23 | skeletal muscle adaptation (GO:0043501) | 3.85827390 |
| 24 | skeletal muscle contraction (GO:0003009) | 3.84485249 |
| 25 | regulation of membrane repolarization (GO:0060306) | 3.83334275 |
| 26 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.83159065 |
| 27 | cardiac muscle contraction (GO:0060048) | 3.80447780 |
| 28 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.69573688 |
| 29 | creatine metabolic process (GO:0006600) | 3.69539130 |
| 30 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.68858840 |
| 31 | regulation of cell communication by electrical coupling (GO:0010649) | 3.67439081 |
| 32 | vocalization behavior (GO:0071625) | 3.67254046 |
| 33 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.67090590 |
| 34 | response to inactivity (GO:0014854) | 3.64303255 |
| 35 | regulation of actin filament-based movement (GO:1903115) | 3.62519266 |
| 36 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.55157354 |
| 37 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.53787935 |
| 38 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.53042408 |
| 39 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.52315372 |
| 40 | response to mercury ion (GO:0046689) | 3.51533071 |
| 41 | sarcomere organization (GO:0045214) | 3.43906996 |
| 42 | carnitine transmembrane transport (GO:1902603) | 3.41872789 |
| 43 | muscle contraction (GO:0006936) | 3.41071177 |
| 44 | cellular potassium ion homeostasis (GO:0030007) | 3.39535177 |
| 45 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.37960818 |
| 46 | regulation of cofactor metabolic process (GO:0051193) | 3.37499476 |
| 47 | regulation of coenzyme metabolic process (GO:0051196) | 3.37499476 |
| 48 | muscle hypertrophy (GO:0014896) | 3.35442190 |
| 49 | * response to muscle activity (GO:0014850) | 3.35402876 |
| 50 | ATP synthesis coupled proton transport (GO:0015986) | 3.35061873 |
| 51 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.35061873 |
| 52 | regulation of relaxation of muscle (GO:1901077) | 3.33363991 |
| 53 | sodium ion export (GO:0071436) | 3.31715596 |
| 54 | carnitine transport (GO:0015879) | 3.31507951 |
| 55 | amino-acid betaine transport (GO:0015838) | 3.31507951 |
| 56 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.31228108 |
| 57 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.28631782 |
| 58 | L-phenylalanine catabolic process (GO:0006559) | 3.28631782 |
| 59 | myofibril assembly (GO:0030239) | 3.27468926 |
| 60 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.27087139 |
| 61 | cardiac muscle cell development (GO:0055013) | 3.26754348 |
| 62 | relaxation of cardiac muscle (GO:0055119) | 3.26414809 |
| 63 | * respiratory electron transport chain (GO:0022904) | 3.26184212 |
| 64 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.25882378 |
| 65 | succinate metabolic process (GO:0006105) | 3.25470899 |
| 66 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.23382518 |
| 67 | locomotory exploration behavior (GO:0035641) | 3.22605175 |
| 68 | muscle tissue morphogenesis (GO:0060415) | 3.22033638 |
| 69 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.21698333 |
| 70 | detection of calcium ion (GO:0005513) | 3.21121792 |
| 71 | ketone body metabolic process (GO:1902224) | 3.19044610 |
| 72 | * electron transport chain (GO:0022900) | 3.17130248 |
| 73 | cardiac muscle cell action potential (GO:0086001) | 3.16845801 |
| 74 | potassium ion import (GO:0010107) | 3.16810084 |
| 75 | glycogen catabolic process (GO:0005980) | 3.16510992 |
| 76 | membrane repolarization (GO:0086009) | 3.14577406 |
| 77 | NADH metabolic process (GO:0006734) | 3.13602220 |
| 78 | striated muscle atrophy (GO:0014891) | 3.13315659 |
| 79 | cardiac conduction (GO:0061337) | 3.12941560 |
| 80 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.12037061 |
| 81 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.09926413 |
| 82 | membrane repolarization during action potential (GO:0086011) | 3.09591451 |
| 83 | muscle system process (GO:0003012) | 3.08575438 |
| 84 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.06903004 |
| 85 | cardiac muscle hypertrophy (GO:0003300) | 3.06409115 |
| 86 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.06352052 |
| 87 | striated muscle adaptation (GO:0014888) | 3.06225184 |
| 88 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.05183677 |
| 89 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.03897052 |
| 90 | L-phenylalanine metabolic process (GO:0006558) | 3.03897052 |
| 91 | muscle cell cellular homeostasis (GO:0046716) | 3.03419871 |
| 92 | cardiac cell development (GO:0055006) | 3.02084565 |
| 93 | relaxation of muscle (GO:0090075) | 3.01928399 |
| 94 | regulation of lipoprotein metabolic process (GO:0050746) | 3.01551300 |
| 95 | regulation of the force of heart contraction (GO:0002026) | 3.01090767 |
| 96 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.00686557 |
| 97 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.99132992 |
| 98 | regulation of potassium ion transmembrane transport (GO:1901379) | 2.98970682 |
| 99 | synaptic vesicle exocytosis (GO:0016079) | 2.98551631 |
| 100 | striated muscle contraction (GO:0006941) | 2.98387291 |
| 101 | tyrosine metabolic process (GO:0006570) | 2.97757962 |
| 102 | 2-oxoglutarate metabolic process (GO:0006103) | 2.97318539 |
| 103 | glucan catabolic process (GO:0009251) | 2.97029729 |
| 104 | gamma-aminobutyric acid transport (GO:0015812) | 2.96971955 |
| 105 | glutamate receptor signaling pathway (GO:0007215) | 2.96498748 |
| 106 | regulation of striated muscle contraction (GO:0006942) | 2.96241264 |
| 107 | regulation of protein activation cascade (GO:2000257) | 2.96027947 |
| 108 | striated muscle hypertrophy (GO:0014897) | 2.94326435 |
| 109 | proline transport (GO:0015824) | 2.92313220 |
| 110 | regulation of cardiac muscle contraction (GO:0055117) | 2.92086481 |
| 111 | regulation of complement activation (GO:0030449) | 2.92081928 |
| 112 | adult heart development (GO:0007512) | 2.91774804 |
| 113 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 2.90396547 |
| 114 | neuron cell-cell adhesion (GO:0007158) | 2.87695103 |
| 115 | quaternary ammonium group transport (GO:0015697) | 2.87175178 |
| 116 | glutamate secretion (GO:0014047) | 2.84514729 |
| 117 | muscle atrophy (GO:0014889) | 2.83057826 |
| 118 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.82717655 |
| 119 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.82717655 |
| 120 | * regulation of glutamate receptor signaling pathway (GO:1900449) | 2.82283996 |
| 121 | heart contraction (GO:0060047) | 2.81188634 |
| 122 | heart process (GO:0003015) | 2.81188634 |
| 123 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.79751370 |
| 124 | neuronal action potential propagation (GO:0019227) | 2.79323656 |
| 125 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.79254965 |
| 126 | cellular polysaccharide catabolic process (GO:0044247) | 2.77829258 |
| 127 | oxaloacetate metabolic process (GO:0006107) | 2.77763339 |
| 128 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.77733667 |
| 129 | alanine transport (GO:0032328) | 2.77234104 |
| 130 | carnitine shuttle (GO:0006853) | 2.76417554 |
| 131 | positive regulation of potassium ion transport (GO:0043268) | 2.76176917 |
| 132 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.75506366 |
| 133 | striatum development (GO:0021756) | 2.75012736 |
| 134 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.73508398 |
| 135 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.73219127 |
| 136 | regulation of sarcomere organization (GO:0060297) | 2.72914042 |
| 137 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.72833580 |
| 138 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.72833580 |
| 139 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.72643264 |
| 140 | regulation of sulfur metabolic process (GO:0042762) | 2.70020748 |
| 141 | protein localization to synapse (GO:0035418) | 2.69724582 |
| 142 | * regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.69680307 |
| 143 | muscle filament sliding (GO:0030049) | 2.69475967 |
| 144 | actin-myosin filament sliding (GO:0033275) | 2.69475967 |
| 145 | multicellular organismal signaling (GO:0035637) | 2.68696868 |
| 146 | adrenergic receptor signaling pathway (GO:0071875) | 2.68032709 |
| 147 | muscle fiber development (GO:0048747) | 2.67542579 |
| 148 | cardiac muscle adaptation (GO:0014887) | 2.66681828 |
| 149 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.66681828 |
| 150 | muscle hypertrophy in response to stress (GO:0003299) | 2.66681828 |
| 151 | membrane depolarization during action potential (GO:0086010) | 2.64497655 |
| 152 | synaptic vesicle maturation (GO:0016188) | 2.64385437 |
| 153 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.62927760 |
| 154 | neurotransmitter secretion (GO:0007269) | 2.62202713 |
| 155 | positive regulation of sodium ion transport (GO:0010765) | 2.60935595 |
| 156 | regulation of heart rate (GO:0002027) | 2.60720414 |
| 157 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.60356476 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.90740882 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.44749976 |
| 3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.69904740 |
| 4 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.64896592 |
| 5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.62034577 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.42223929 |
| 7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.23293579 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.23293579 |
| 9 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.19205026 |
| 10 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.16575210 |
| 11 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.11882637 |
| 12 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.11474661 |
| 13 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.04570027 |
| 14 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.04461379 |
| 15 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.04112341 |
| 16 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.00485670 |
| 17 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.00149786 |
| 18 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.97472708 |
| 19 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.97090394 |
| 20 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.95709400 |
| 21 | * RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.92966889 |
| 22 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.90980879 |
| 23 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.90454968 |
| 24 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.89201635 |
| 25 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.87781499 |
| 26 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.80110620 |
| 27 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.77539086 |
| 28 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.75900827 |
| 29 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.74004127 |
| 30 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.73906360 |
| 31 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.72566803 |
| 32 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.72522280 |
| 33 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.68844806 |
| 34 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.68622753 |
| 35 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.68028565 |
| 36 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.66834836 |
| 37 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.66802664 |
| 38 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.62425995 |
| 39 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.61727767 |
| 40 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.61355910 |
| 41 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.56805565 |
| 42 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.54376760 |
| 43 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.52728661 |
| 44 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.52072963 |
| 45 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.51088308 |
| 46 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.48835738 |
| 47 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.46358737 |
| 48 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.46255211 |
| 49 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.45808090 |
| 50 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.42294709 |
| 51 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.42118879 |
| 52 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.40889720 |
| 53 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.40811168 |
| 54 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.39781177 |
| 55 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.39622043 |
| 56 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.39206956 |
| 57 | VDR_22108803_ChIP-Seq_LS180_Human | 1.37786678 |
| 58 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.37200248 |
| 59 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.36983801 |
| 60 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.36841564 |
| 61 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.35339500 |
| 62 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.33883521 |
| 63 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.32504583 |
| 64 | AR_25329375_ChIP-Seq_VCAP_Human | 1.29981160 |
| 65 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.28940053 |
| 66 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.28842460 |
| 67 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.27969178 |
| 68 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.26706125 |
| 69 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.26671050 |
| 70 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.26323813 |
| 71 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.25817949 |
| 72 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.25003285 |
| 73 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.24183199 |
| 74 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.23509902 |
| 75 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.23046596 |
| 76 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.22551466 |
| 77 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.22061811 |
| 78 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.21597966 |
| 79 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.20708685 |
| 80 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.20575716 |
| 81 | STAT3_23295773_ChIP-Seq_U87_Human | 1.19916218 |
| 82 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.19890392 |
| 83 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.19890392 |
| 84 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.19734960 |
| 85 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.18640040 |
| 86 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.18097871 |
| 87 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.18087344 |
| 88 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.18051632 |
| 89 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.17585064 |
| 90 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.16754780 |
| 91 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.16534985 |
| 92 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.16534985 |
| 93 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.16450856 |
| 94 | CJUN_26792858_Chip-Seq_BT549_Human | 1.15409474 |
| 95 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.15134996 |
| 96 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.15037073 |
| 97 | GATA1_22025678_ChIP-Seq_K562_Human | 1.14795338 |
| 98 | FUS_26573619_Chip-Seq_HEK293_Human | 1.13552157 |
| 99 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.13023644 |
| 100 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.11458995 |
| 101 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.11458995 |
| 102 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.11170935 |
| 103 | * AR_19668381_ChIP-Seq_PC3_Human | 1.10286078 |
| 104 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.09983935 |
| 105 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.09927824 |
| 106 | TP53_16413492_ChIP-PET_HCT116_Human | 1.08349024 |
| 107 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.07961665 |
| 108 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.07819015 |
| 109 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.07000305 |
| 110 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.06371679 |
| 111 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.06308011 |
| 112 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06131978 |
| 113 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.06131978 |
| 114 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.05867825 |
| 115 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.05826936 |
| 116 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.05612967 |
| 117 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.05120380 |
| 118 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.05032693 |
| 119 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.04786230 |
| 120 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.03391587 |
| 121 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.03338466 |
| 122 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.03300127 |
| 123 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.02600822 |
| 124 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.02421605 |
| 125 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.01797315 |
| 126 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.01300288 |
| 127 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.01054061 |
| 128 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.00288486 |
| 129 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00199722 |
| 130 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.99320100 |
| 131 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.98115189 |
| 132 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.97983036 |
| 133 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.95969988 |
| 134 | RXR_22108803_ChIP-Seq_LS180_Human | 0.95569468 |
| 135 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.94997459 |
| 136 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.94142044 |
| 137 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.93917733 |
| 138 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.92606664 |
| 139 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92563544 |
| 140 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.92230708 |
| 141 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.90850396 |
| 142 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.89748202 |
| 143 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.88657307 |
| 144 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.88366985 |
| 145 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.87768828 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 4.19959687 |
| 2 | MP0004215_abnormal_myocardial_fiber | 3.65894666 |
| 3 | MP0004859_abnormal_synaptic_plasticity | 3.45678023 |
| 4 | MP0000751_myopathy | 3.34743542 |
| 5 | MP0004084_abnormal_cardiac_muscle | 3.22954279 |
| 6 | MP0003880_abnormal_central_pattern | 2.86666271 |
| 7 | MP0004036_abnormal_muscle_relaxation | 2.57669566 |
| 8 | MP0003635_abnormal_synaptic_transmissio | 2.53293078 |
| 9 | * MP0003646_muscle_fatigue | 2.48876031 |
| 10 | MP0003137_abnormal_impulse_conducting | 2.37895498 |
| 11 | MP0005408_hypopigmentation | 2.36718460 |
| 12 | MP0005330_cardiomyopathy | 2.33683725 |
| 13 | MP0000749_muscle_degeneration | 2.29922924 |
| 14 | MP0009745_abnormal_behavioral_response | 2.29290007 |
| 15 | * MP0009046_muscle_twitch | 2.24646048 |
| 16 | MP0005670_abnormal_white_adipose | 2.23568506 |
| 17 | MP0003195_calcinosis | 2.23563803 |
| 18 | MP0004270_analgesia | 2.16235006 |
| 19 | * MP0002972_abnormal_cardiac_muscle | 2.11207581 |
| 20 | * MP0002064_seizures | 2.01378828 |
| 21 | MP0002063_abnormal_learning/memory/cond | 2.01200763 |
| 22 | MP0004145_abnormal_muscle_electrophysio | 1.97631138 |
| 23 | MP0004130_abnormal_muscle_cell | 1.96308094 |
| 24 | * MP0004484_altered_response_of | 1.94100662 |
| 25 | MP0008775_abnormal_heart_ventricle | 1.92901668 |
| 26 | * MP0005620_abnormal_muscle_contractility | 1.89827547 |
| 27 | MP0004043_abnormal_pH_regulation | 1.87562426 |
| 28 | * MP0004085_abnormal_heartbeat | 1.86993598 |
| 29 | * MP0001486_abnormal_startle_reflex | 1.85192820 |
| 30 | * MP0002572_abnormal_emotion/affect_behav | 1.82030341 |
| 31 | MP0002272_abnormal_nervous_system | 1.77543840 |
| 32 | MP0001440_abnormal_grooming_behavior | 1.75631515 |
| 33 | MP0003136_yellow_coat_color | 1.72636964 |
| 34 | MP0005085_abnormal_gallbladder_physiolo | 1.70192061 |
| 35 | MP0005171_absent_coat_pigmentation | 1.67754681 |
| 36 | * MP0004087_abnormal_muscle_fiber | 1.65993565 |
| 37 | MP0001968_abnormal_touch/_nociception | 1.65805203 |
| 38 | MP0005423_abnormal_somatic_nervous | 1.62526035 |
| 39 | MP0002139_abnormal_hepatobiliary_system | 1.56660392 |
| 40 | MP0001501_abnormal_sleep_pattern | 1.52985496 |
| 41 | MP0002734_abnormal_mechanical_nocicepti | 1.50584217 |
| 42 | MP0009780_abnormal_chondrocyte_physiolo | 1.47274424 |
| 43 | MP0001984_abnormal_olfaction | 1.46354791 |
| 44 | * MP0002067_abnormal_sensory_capabilities | 1.45009319 |
| 45 | * MP0006138_congestive_heart_failure | 1.43169262 |
| 46 | * MP0005385_cardiovascular_system_phenoty | 1.42862654 |
| 47 | * MP0001544_abnormal_cardiovascular_syste | 1.42862654 |
| 48 | MP0002822_catalepsy | 1.42722700 |
| 49 | MP0005646_abnormal_pituitary_gland | 1.37956092 |
| 50 | MP0002735_abnormal_chemical_nociception | 1.36958852 |
| 51 | MP0005551_abnormal_eye_electrophysiolog | 1.35254080 |
| 52 | MP0005187_abnormal_penis_morphology | 1.32545862 |
| 53 | MP0005075_abnormal_melanosome_morpholog | 1.32373469 |
| 54 | MP0002736_abnormal_nociception_after | 1.31375635 |
| 55 | * MP0005386_behavior/neurological_phenoty | 1.31302608 |
| 56 | * MP0004924_abnormal_behavior | 1.31302608 |
| 57 | MP0008569_lethality_at_weaning | 1.29721915 |
| 58 | * MP0002106_abnormal_muscle_physiology | 1.29023058 |
| 59 | MP0004885_abnormal_endolymph | 1.28747588 |
| 60 | MP0000569_abnormal_digit_pigmentation | 1.25536391 |
| 61 | MP0004381_abnormal_hair_follicle | 1.24699471 |
| 62 | MP0010630_abnormal_cardiac_muscle | 1.22396006 |
| 63 | MP0003045_fibrosis | 1.21262786 |
| 64 | MP0005365_abnormal_bile_salt | 1.20840180 |
| 65 | MP0003878_abnormal_ear_physiology | 1.20446447 |
| 66 | MP0005377_hearing/vestibular/ear_phenot | 1.20446447 |
| 67 | MP0000747_muscle_weakness | 1.20423851 |
| 68 | MP0001661_extended_life_span | 1.18022959 |
| 69 | MP0002557_abnormal_social/conspecific_i | 1.16615752 |
| 70 | MP0000371_diluted_coat_color | 1.15766546 |
| 71 | MP0002332_abnormal_exercise_endurance | 1.14440897 |
| 72 | * MP0006036_abnormal_mitochondrial_physio | 1.13833955 |
| 73 | MP0002909_abnormal_adrenal_gland | 1.12410786 |
| 74 | MP0001324_abnormal_eye_pigmentation | 1.12318340 |
| 75 | MP0002269_muscular_atrophy | 1.11694354 |
| 76 | MP0004510_myositis | 1.11512688 |
| 77 | MP0006276_abnormal_autonomic_nervous | 1.10986412 |
| 78 | * MP0005369_muscle_phenotype | 1.10855875 |
| 79 | MP0003329_amyloid_beta_deposits | 1.06746013 |
| 80 | MP0005409_darkened_coat_color | 1.06422804 |
| 81 | MP0005248_abnormal_Harderian_gland | 1.06401573 |
| 82 | MP0006035_abnormal_mitochondrial_morpho | 1.06193177 |
| 83 | MP0001970_abnormal_pain_threshold | 1.06087544 |
| 84 | MP0002095_abnormal_skin_pigmentation | 1.05376957 |
| 85 | MP0005451_abnormal_body_composition | 1.04660392 |
| 86 | MP0000778_abnormal_nervous_system | 1.03867096 |
| 87 | MP0000750_abnormal_muscle_regeneration | 1.03806086 |
| 88 | MP0010329_abnormal_lipoprotein_level | 1.03148440 |
| 89 | MP0002127_abnormal_cardiovascular_syste | 1.02708958 |
| 90 | MP0001485_abnormal_pinna_reflex | 1.00634729 |
| 91 | MP0002108_abnormal_muscle_morphology | 0.99794864 |
| 92 | MP0002877_abnormal_melanocyte_morpholog | 0.99694193 |
| 93 | MP0002733_abnormal_thermal_nociception | 0.99687348 |
| 94 | MP0000015_abnormal_ear_pigmentation | 0.99415239 |
| 95 | MP0004858_abnormal_nervous_system | 0.98676226 |
| 96 | MP0003252_abnormal_bile_duct | 0.97513606 |
| 97 | MP0002184_abnormal_innervation | 0.96731011 |
| 98 | * MP0005535_abnormal_body_temperature | 0.96635034 |
| 99 | MP0003950_abnormal_plasma_membrane | 0.95460222 |
| 100 | MP0001529_abnormal_vocalization | 0.94960194 |
| 101 | MP0002102_abnormal_ear_morphology | 0.94077636 |
| 102 | * MP0000759_abnormal_skeletal_muscle | 0.93597859 |
| 103 | MP0002876_abnormal_thyroid_physiology | 0.93301378 |
| 104 | * MP0002066_abnormal_motor_capabilities/c | 0.93092458 |
| 105 | MP0005266_abnormal_metabolism | 0.92866108 |
| 106 | MP0003879_abnormal_hair_cell | 0.92300813 |
| 107 | MP0001502_abnormal_circadian_rhythm | 0.92080784 |
| 108 | MP0000230_abnormal_systemic_arterial | 0.90663310 |
| 109 | MP0005253_abnormal_eye_physiology | 0.87399551 |
| 110 | MP0000372_irregular_coat_pigmentation | 0.86885258 |
| 111 | MP0003221_abnormal_cardiomyocyte_apopto | 0.86761685 |
| 112 | * MP0002882_abnormal_neuron_morphology | 0.84212217 |
| 113 | * MP0004142_abnormal_muscle_tone | 0.84183590 |
| 114 | MP0003633_abnormal_nervous_system | 0.83728019 |
| 115 | MP0005332_abnormal_amino_acid | 0.83369923 |
| 116 | MP0002638_abnormal_pupillary_reflex | 0.82791170 |
| 117 | MP0002938_white_spotting | 0.82456689 |
| 118 | * MP0002229_neurodegeneration | 0.81875513 |
| 119 | MP0008875_abnormal_xenobiotic_pharmacok | 0.80370532 |
| 120 | * MP0002971_abnormal_brown_adipose | 0.80342876 |
| 121 | MP0000013_abnormal_adipose_tissue | 0.79366864 |
| 122 | MP0003122_maternal_imprinting | 0.77756946 |
| 123 | MP0001756_abnormal_urination | 0.77453075 |
| 124 | MP0002090_abnormal_vision | 0.77321194 |
| 125 | MP0003690_abnormal_glial_cell | 0.77226755 |
| 126 | MP0005174_abnormal_tail_pigmentation | 0.76401055 |
| 127 | MP0004147_increased_porphyrin_level | 0.74767834 |
| 128 | MP0001963_abnormal_hearing_physiology | 0.71522629 |
| 129 | MP0000733_abnormal_muscle_development | 0.70390826 |
| 130 | MP0004811_abnormal_neuron_physiology | 0.70142962 |
| 131 | MP0002075_abnormal_coat/hair_pigmentati | 0.70005554 |
| 132 | MP0005666_abnormal_adipose_tissue | 0.67899158 |
| 133 | MP0005360_urolithiasis | 0.67116193 |
| 134 | MP0000955_abnormal_spinal_cord | 0.66890779 |
| 135 | * MP0004233_abnormal_muscle_weight | 0.66472798 |
| 136 | MP0003868_abnormal_feces_composition | 0.66411139 |
| 137 | * MP0002118_abnormal_lipid_homeostasis | 0.61967338 |
| 138 | MP0002168_other_aberrant_phenotype | 0.60761381 |
| 139 | MP0000003_abnormal_adipose_tissue | 0.58902790 |
| 140 | MP0010368_abnormal_lymphatic_system | 0.58667179 |
| 141 | MP0005257_abnormal_intraocular_pressure | 0.57809343 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber inclusion bodies (HP:0100299) | 7.41477053 |
| 2 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 7.10868477 |
| 3 | Nemaline bodies (HP:0003798) | 7.05346087 |
| 4 | Sudden death (HP:0001699) | 5.30517285 |
| 5 | Type 1 muscle fiber predominance (HP:0003803) | 5.09097133 |
| 6 | Focal motor seizures (HP:0011153) | 4.82313066 |
| 7 | Atrial fibrillation (HP:0005110) | 4.42308993 |
| 8 | Syncope (HP:0001279) | 4.41510276 |
| 9 | Exercise-induced myalgia (HP:0003738) | 4.29725367 |
| 10 | Primary atrial arrhythmia (HP:0001692) | 4.16412565 |
| 11 | Calf muscle hypertrophy (HP:0008981) | 3.98981204 |
| 12 | Supraventricular tachycardia (HP:0004755) | 3.95515287 |
| 13 | Prolonged QT interval (HP:0001657) | 3.90412812 |
| 14 | Supraventricular arrhythmia (HP:0005115) | 3.83240868 |
| 15 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.71144235 |
| 16 | Exercise-induced muscle cramps (HP:0003710) | 3.61616150 |
| 17 | Abnormality of the calf musculature (HP:0001430) | 3.61051143 |
| 18 | Distal arthrogryposis (HP:0005684) | 3.48254622 |
| 19 | Ventricular tachycardia (HP:0004756) | 3.47479166 |
| 20 | Myoglobinuria (HP:0002913) | 3.41943005 |
| 21 | Neck muscle weakness (HP:0000467) | 3.37623692 |
| 22 | Pheochromocytoma (HP:0002666) | 3.37239643 |
| 23 | Frequent falls (HP:0002359) | 3.35359156 |
| 24 | Rimmed vacuoles (HP:0003805) | 3.29928791 |
| 25 | Acute necrotizing encephalopathy (HP:0006965) | 3.27815945 |
| 26 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.27793822 |
| 27 | Ventricular fibrillation (HP:0001663) | 3.24486131 |
| 28 | Hyperventilation (HP:0002883) | 3.23291203 |
| 29 | Ventricular arrhythmia (HP:0004308) | 3.17406641 |
| 30 | Focal seizures (HP:0007359) | 3.15854714 |
| 31 | Febrile seizures (HP:0002373) | 3.05396893 |
| 32 | Bundle branch block (HP:0011710) | 3.05154466 |
| 33 | Myopathic facies (HP:0002058) | 3.03750708 |
| 34 | Abnormal EKG (HP:0003115) | 2.98650607 |
| 35 | Epileptic encephalopathy (HP:0200134) | 2.97740437 |
| 36 | Palpitations (HP:0001962) | 2.96795856 |
| 37 | Neuroendocrine neoplasm (HP:0100634) | 2.94624301 |
| 38 | Progressive macrocephaly (HP:0004481) | 2.93699127 |
| 39 | Acute encephalopathy (HP:0006846) | 2.92061860 |
| 40 | Round ear (HP:0100830) | 2.88227784 |
| 41 | Lipoatrophy (HP:0100578) | 2.86393186 |
| 42 | Myokymia (HP:0002411) | 2.85399107 |
| 43 | Ketoacidosis (HP:0001993) | 2.82900261 |
| 44 | Left ventricular hypertrophy (HP:0001712) | 2.81999944 |
| 45 | Atonic seizures (HP:0010819) | 2.78699449 |
| 46 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.78313963 |
| 47 | Right ventricular cardiomyopathy (HP:0011663) | 2.78220835 |
| 48 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.76578659 |
| 49 | EMG: neuropathic changes (HP:0003445) | 2.69492548 |
| 50 | Central scotoma (HP:0000603) | 2.66850917 |
| 51 | Distal lower limb muscle weakness (HP:0009053) | 2.65885777 |
| 52 | Heart block (HP:0012722) | 2.63352434 |
| 53 | Hyperkalemia (HP:0002153) | 2.59945273 |
| 54 | Areflexia of lower limbs (HP:0002522) | 2.58642445 |
| 55 | Mitochondrial inheritance (HP:0001427) | 2.57628073 |
| 56 | Generalized tonic-clonic seizures (HP:0002069) | 2.56660016 |
| 57 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.54833217 |
| 58 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.54673781 |
| 59 | Hypoplasia of the fovea (HP:0007750) | 2.54673781 |
| 60 | Subaortic stenosis (HP:0001682) | 2.53708089 |
| 61 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.53708089 |
| 62 | Absence seizures (HP:0002121) | 2.50249530 |
| 63 | Visual hallucinations (HP:0002367) | 2.49880838 |
| 64 | Hepatic necrosis (HP:0002605) | 2.49100835 |
| 65 | Complement deficiency (HP:0004431) | 2.46900014 |
| 66 | Blue irides (HP:0000635) | 2.44951089 |
| 67 | Dilated cardiomyopathy (HP:0001644) | 2.44884885 |
| 68 | Generalized muscle weakness (HP:0003324) | 2.43228308 |
| 69 | Muscle fiber splitting (HP:0003555) | 2.42936484 |
| 70 | Cerebral edema (HP:0002181) | 2.41981318 |
| 71 | Increased CSF lactate (HP:0002490) | 2.40320609 |
| 72 | EMG: myopathic abnormalities (HP:0003458) | 2.38024343 |
| 73 | Atrioventricular block (HP:0001678) | 2.37883685 |
| 74 | Increased connective tissue (HP:0009025) | 2.37465522 |
| 75 | Abnormal atrioventricular conduction (HP:0005150) | 2.36028200 |
| 76 | Abnormality of the fovea (HP:0000493) | 2.35072139 |
| 77 | Dysmetric saccades (HP:0000641) | 2.34203996 |
| 78 | Progressive inability to walk (HP:0002505) | 2.30738988 |
| 79 | Progressive cerebellar ataxia (HP:0002073) | 2.30182087 |
| 80 | Hepatocellular necrosis (HP:0001404) | 2.28055536 |
| 81 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.26485448 |
| 82 | Dysdiadochokinesis (HP:0002075) | 2.25494833 |
| 83 | Broad-based gait (HP:0002136) | 2.24445180 |
| 84 | Deep venous thrombosis (HP:0002625) | 2.24431426 |
| 85 | Asymmetric septal hypertrophy (HP:0001670) | 2.23342655 |
| 86 | Hyporeflexia of lower limbs (HP:0002600) | 2.22498156 |
| 87 | Prolonged partial thromboplastin time (HP:0003645) | 2.22073509 |
| 88 | Ragged-red muscle fibers (HP:0003200) | 2.20246026 |
| 89 | Dialeptic seizures (HP:0011146) | 2.19557088 |
| 90 | Ulnar deviation of the wrist (HP:0003049) | 2.19080833 |
| 91 | Abnormality of alanine metabolism (HP:0010916) | 2.18735357 |
| 92 | Hyperalaninemia (HP:0003348) | 2.18735357 |
| 93 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.18735357 |
| 94 | Anxiety (HP:0000739) | 2.17712209 |
| 95 | Absent phalangeal crease (HP:0006109) | 2.17223115 |
| 96 | Ocular albinism (HP:0001107) | 2.17118992 |
| 97 | Scapular winging (HP:0003691) | 2.16663039 |
| 98 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.15286468 |
| 99 | Hypoplastic left heart (HP:0004383) | 2.14856695 |
| 100 | Proximal amyotrophy (HP:0007126) | 2.13960144 |
| 101 | Athetosis (HP:0002305) | 2.13545481 |
| 102 | Muscle stiffness (HP:0003552) | 2.11594430 |
| 103 | Conjunctival hamartoma (HP:0100780) | 2.08423794 |
| 104 | Lactic acidosis (HP:0003128) | 2.05810036 |
| 105 | Increased serum pyruvate (HP:0003542) | 2.05599174 |
| 106 | Abnormality of glycolysis (HP:0004366) | 2.05599174 |
| 107 | Hypobetalipoproteinemia (HP:0003563) | 2.05304516 |
| 108 | Optic disc pallor (HP:0000543) | 2.05026333 |
| 109 | Ketosis (HP:0001946) | 2.04577917 |
| 110 | Abnormality of potassium homeostasis (HP:0011042) | 2.03452546 |
| 111 | Gowers sign (HP:0003391) | 2.00762624 |
| 112 | Gaze-evoked nystagmus (HP:0000640) | 2.00434715 |
| 113 | Myotonia (HP:0002486) | 1.99100416 |
| 114 | Increased variability in muscle fiber diameter (HP:0003557) | 1.96455990 |
| 115 | Hypoalphalipoproteinemia (HP:0003233) | 1.94795809 |
| 116 | Abnormal social behavior (HP:0012433) | 1.94653782 |
| 117 | Impaired social interactions (HP:0000735) | 1.94653782 |
| 118 | Abnormality of the foot musculature (HP:0001436) | 1.93653749 |
| 119 | Iris hypopigmentation (HP:0007730) | 1.93441972 |
| 120 | Hypoglycemic coma (HP:0001325) | 1.91988427 |
| 121 | Rhabdomyolysis (HP:0003201) | 1.91612508 |
| 122 | Poor eye contact (HP:0000817) | 1.90293131 |
| 123 | Abnormal finger flexion creases (HP:0006143) | 1.89130548 |
| 124 | Exercise intolerance (HP:0003546) | 1.88599328 |
| 125 | Action tremor (HP:0002345) | 1.88179293 |
| 126 | Hypolipoproteinemia (HP:0010981) | 1.87814797 |
| 127 | Hypokalemia (HP:0002900) | 1.84715342 |
| 128 | Status epilepticus (HP:0002133) | 1.84172232 |
| 129 | Dicarboxylic aciduria (HP:0003215) | 1.84080404 |
| 130 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.84080404 |
| 131 | Increased circulating renin level (HP:0000848) | 1.83995750 |
| 132 | Hamartoma of the eye (HP:0010568) | 1.83793277 |
| 133 | Tinnitus (HP:0000360) | 1.82376155 |
| 134 | Metabolic alkalosis (HP:0200114) | 1.81963147 |
| 135 | Vascular calcification (HP:0004934) | 1.81020193 |
| 136 | Increased intramyocellular lipid droplets (HP:0012240) | 1.80847251 |
| 137 | Increased muscle lipid content (HP:0009058) | 1.80273752 |
| 138 | Hyperactive renin-angiotensin system (HP:0000841) | 1.80239901 |
| 139 | Respiratory failure (HP:0002878) | 1.80192639 |
| 140 | White forelock (HP:0002211) | 1.80153358 |
| 141 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.79636366 |
| 142 | Scotoma (HP:0000575) | 1.79467474 |
| 143 | Foot dorsiflexor weakness (HP:0009027) | 1.79256458 |
| 144 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.77961806 |
| 145 | Malignant hyperthermia (HP:0002047) | 1.77485357 |
| 146 | Difficulty running (HP:0009046) | 1.76609149 |
| 147 | Truncal ataxia (HP:0002078) | 1.76251161 |
| 148 | Hyperglycinuria (HP:0003108) | 1.74986776 |
| 149 | Hypokalemic alkalosis (HP:0001949) | 1.74286881 |
| 150 | Epidermoid cyst (HP:0200040) | 1.73170179 |
| 151 | Muscular dystrophy (HP:0003560) | 1.72788733 |
| 152 | Neoplasm of the adrenal gland (HP:0100631) | 1.72014244 |
| 153 | Calcaneovalgus deformity (HP:0001848) | 1.71758081 |
| 154 | Abnormality of complement system (HP:0005339) | 1.70323012 |
| 155 | Joint hemorrhage (HP:0005261) | 1.69527405 |
| 156 | Patchy hypopigmentation of hair (HP:0011365) | 1.66681888 |
| 157 | Generalized hypopigmentation of hair (HP:0011358) | 1.65427245 |
| 158 | Generalized hypopigmentation (HP:0007513) | 1.63324371 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | LMTK2 | 3.10214620 |
| 2 | LATS1 | 3.05782484 |
| 3 | PHKG1 | 2.95986168 |
| 4 | PHKG2 | 2.95986168 |
| 5 | EPHA4 | 2.95198668 |
| 6 | NTRK3 | 2.83823728 |
| 7 | MUSK | 2.70352124 |
| 8 | OBSCN | 2.61608530 |
| 9 | MAP3K4 | 2.57586029 |
| 10 | MAP2K7 | 2.46010282 |
| 11 | PDK3 | 2.43304164 |
| 12 | PDK4 | 2.43304164 |
| 13 | FRK | 2.39654710 |
| 14 | CASK | 2.07258533 |
| 15 | MYLK | 1.94780221 |
| 16 | TNIK | 1.93552617 |
| 17 | WNK4 | 1.86947580 |
| 18 | PIK3CG | 1.84728323 |
| 19 | MAP2K4 | 1.80084220 |
| 20 | MAP3K9 | 1.74241812 |
| 21 | MARK1 | 1.71181690 |
| 22 | STK24 | 1.65980986 |
| 23 | ACVR1B | 1.61578512 |
| 24 | NTRK2 | 1.57704089 |
| 25 | PINK1 | 1.51353850 |
| 26 | MINK1 | 1.49768702 |
| 27 | DMPK | 1.46079069 |
| 28 | SGK2 | 1.43859488 |
| 29 | PRKD3 | 1.42463354 |
| 30 | ERBB3 | 1.37507103 |
| 31 | PIK3CA | 1.36573305 |
| 32 | TRPM7 | 1.36188652 |
| 33 | PDK2 | 1.32028704 |
| 34 | TTN | 1.28849959 |
| 35 | STK39 | 1.27437845 |
| 36 | OXSR1 | 1.27428166 |
| 37 | STK38 | 1.24478121 |
| 38 | BMPR1B | 1.24027115 |
| 39 | CAMK2A | 1.23359124 |
| 40 | PAK3 | 1.23334914 |
| 41 | SGK494 | 1.21809451 |
| 42 | SGK223 | 1.21809451 |
| 43 | PAK6 | 1.17447515 |
| 44 | INSRR | 1.16542223 |
| 45 | CAMK2D | 1.15584608 |
| 46 | * PRKAA2 | 1.15437899 |
| 47 | MAP3K12 | 1.14531860 |
| 48 | SGK3 | 1.12432713 |
| 49 | GRK7 | 1.08014134 |
| 50 | WNK3 | 1.07721869 |
| 51 | MAPK13 | 1.04918924 |
| 52 | PRPF4B | 1.00198452 |
| 53 | WNK1 | 0.98868604 |
| 54 | MAP3K7 | 0.98232521 |
| 55 | PLK2 | 0.96171227 |
| 56 | DAPK2 | 0.94623146 |
| 57 | MAPK12 | 0.94292378 |
| 58 | PRKCE | 0.92309818 |
| 59 | PTK2B | 0.91759008 |
| 60 | CDK5 | 0.91086104 |
| 61 | KSR1 | 0.90102718 |
| 62 | AKT3 | 0.87330980 |
| 63 | CAMK1 | 0.86448524 |
| 64 | NLK | 0.86290710 |
| 65 | NME1 | 0.85362139 |
| 66 | WEE1 | 0.85083701 |
| 67 | PRKCG | 0.84443464 |
| 68 | EPHA3 | 0.83216396 |
| 69 | PNCK | 0.82099392 |
| 70 | NEK1 | 0.81744795 |
| 71 | BCKDK | 0.81683207 |
| 72 | STK38L | 0.80828971 |
| 73 | KSR2 | 0.80393104 |
| 74 | NEK9 | 0.78952147 |
| 75 | SGK1 | 0.75911152 |
| 76 | MAPKAPK3 | 0.74510808 |
| 77 | GRK5 | 0.73260376 |
| 78 | FGFR3 | 0.72787436 |
| 79 | CDC42BPA | 0.72297877 |
| 80 | MARK3 | 0.72213364 |
| 81 | ROCK1 | 0.71701013 |
| 82 | NTRK1 | 0.70971282 |
| 83 | CAMK2B | 0.70814787 |
| 84 | SIK2 | 0.70099591 |
| 85 | CAMK2G | 0.69600293 |
| 86 | CAMKK1 | 0.68183527 |
| 87 | TRIB3 | 0.67548247 |
| 88 | MST1R | 0.66898799 |
| 89 | RIPK4 | 0.66222067 |
| 90 | PRKAA1 | 0.66185761 |
| 91 | TIE1 | 0.64767371 |
| 92 | MET | 0.64555805 |
| 93 | PRKG1 | 0.63256084 |
| 94 | CAMK4 | 0.62623368 |
| 95 | MAPK7 | 0.60963105 |
| 96 | MAP2K1 | 0.58930732 |
| 97 | CAMK1G | 0.58288543 |
| 98 | PRKCH | 0.57163448 |
| 99 | PKN1 | 0.55641300 |
| 100 | PDPK1 | 0.55207091 |
| 101 | STK3 | 0.54105211 |
| 102 | * PRKACA | 0.54000315 |
| 103 | PDK1 | 0.53071988 |
| 104 | STK11 | 0.52562238 |
| 105 | CCNB1 | 0.51177611 |
| 106 | MAP3K5 | 0.50940991 |
| 107 | PKN2 | 0.50282755 |
| 108 | PRKD1 | 0.49396062 |
| 109 | CAMKK2 | 0.49322131 |
| 110 | UHMK1 | 0.48304443 |
| 111 | MAP3K2 | 0.48112816 |
| 112 | LATS2 | 0.48092015 |
| 113 | MAP3K6 | 0.48079738 |
| 114 | RET | 0.47329175 |
| 115 | FER | 0.46875247 |
| 116 | PRKACG | 0.46526621 |
| 117 | NEK6 | 0.46203279 |
| 118 | CSNK1A1L | 0.45570166 |
| 119 | BMPR2 | 0.43132433 |
| 120 | ROCK2 | 0.43071111 |
| 121 | ERBB4 | 0.43065579 |
| 122 | RPS6KA3 | 0.42253995 |
| 123 | DYRK1A | 0.41675102 |
| 124 | PRKACB | 0.41179002 |
| 125 | EEF2K | 0.40880332 |
| 126 | ILK | 0.40656642 |
| 127 | LIMK1 | 0.40579364 |
| 128 | TGFBR2 | 0.40044560 |
| 129 | MAPK4 | 0.38444146 |
| 130 | FGFR2 | 0.37267710 |
| 131 | EIF2AK3 | 0.34428304 |
| 132 | MAPK10 | 0.34290209 |
| 133 | FGFR1 | 0.28880901 |
| 134 | BRD4 | 0.28346409 |
| 135 | RIPK1 | 0.27500023 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.62934285 |
| 2 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.86928926 |
| 3 | Nicotine addiction_Homo sapiens_hsa05033 | 2.47112692 |
| 4 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.43465455 |
| 5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.34382262 |
| 6 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.21967901 |
| 7 | Parkinsons disease_Homo sapiens_hsa05012 | 2.16393963 |
| 8 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.02741582 |
| 9 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.99269780 |
| 10 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.94418644 |
| 11 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.87477518 |
| 12 | Alzheimers disease_Homo sapiens_hsa05010 | 1.86861982 |
| 13 | GABAergic synapse_Homo sapiens_hsa04727 | 1.83300485 |
| 14 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.79995355 |
| 15 | Histidine metabolism_Homo sapiens_hsa00340 | 1.77407266 |
| 16 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.77375190 |
| 17 | Circadian entrainment_Homo sapiens_hsa04713 | 1.74851538 |
| 18 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.74629341 |
| 19 | Olfactory transduction_Homo sapiens_hsa04740 | 1.71366167 |
| 20 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.68060222 |
| 21 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.66533996 |
| 22 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.66363787 |
| 23 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.64939281 |
| 24 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.62898906 |
| 25 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.60730737 |
| 26 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.60008419 |
| 27 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.58044165 |
| 28 | Morphine addiction_Homo sapiens_hsa05032 | 1.57900731 |
| 29 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.56903483 |
| 30 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.55007028 |
| 31 | Salivary secretion_Homo sapiens_hsa04970 | 1.49431674 |
| 32 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.47945282 |
| 33 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.47844471 |
| 34 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.46978405 |
| 35 | Long-term potentiation_Homo sapiens_hsa04720 | 1.45718526 |
| 36 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.40394422 |
| 37 | Insulin secretion_Homo sapiens_hsa04911 | 1.39320324 |
| 38 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.38391582 |
| 39 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.36977853 |
| 40 | Huntingtons disease_Homo sapiens_hsa05016 | 1.35230271 |
| 41 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.32124802 |
| 42 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.32011774 |
| 43 | Taste transduction_Homo sapiens_hsa04742 | 1.31465294 |
| 44 | Carbon metabolism_Homo sapiens_hsa01200 | 1.30344765 |
| 45 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.27786902 |
| 46 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.27534279 |
| 47 | Renin secretion_Homo sapiens_hsa04924 | 1.22958516 |
| 48 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.22501779 |
| 49 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.21982508 |
| 50 | Phototransduction_Homo sapiens_hsa04744 | 1.20060386 |
| 51 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.15358343 |
| 52 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.10744177 |
| 53 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.10575974 |
| 54 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.08248832 |
| 55 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.07777600 |
| 56 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.07646770 |
| 57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.07045091 |
| 58 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.05735470 |
| 59 | Retinol metabolism_Homo sapiens_hsa00830 | 1.04626366 |
| 60 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.04377235 |
| 61 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.04300520 |
| 62 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.03989811 |
| 63 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.02357752 |
| 64 | ABC transporters_Homo sapiens_hsa02010 | 0.99185969 |
| 65 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.97759366 |
| 66 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.97567097 |
| 67 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.95501169 |
| 68 | Bile secretion_Homo sapiens_hsa04976 | 0.94829937 |
| 69 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.93841625 |
| 70 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.90336100 |
| 71 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.89218302 |
| 72 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.88775578 |
| 73 | Long-term depression_Homo sapiens_hsa04730 | 0.86331611 |
| 74 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.82937313 |
| 75 | * Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.82197012 |
| 76 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.81482922 |
| 77 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.78768284 |
| 78 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.78543904 |
| 79 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.78471073 |
| 80 | Cocaine addiction_Homo sapiens_hsa05030 | 0.74456383 |
| 81 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.73781148 |
| 82 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.70255948 |
| 83 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.69874018 |
| 84 | Gap junction_Homo sapiens_hsa04540 | 0.68776036 |
| 85 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.68571164 |
| 86 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.64812126 |
| 87 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.64064927 |
| 88 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.63688413 |
| 89 | Melanogenesis_Homo sapiens_hsa04916 | 0.62450278 |
| 90 | Circadian rhythm_Homo sapiens_hsa04710 | 0.62136493 |
| 91 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.57804035 |
| 92 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.57743604 |
| 93 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.56165088 |
| 94 | Tight junction_Homo sapiens_hsa04530 | 0.55584828 |
| 95 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.55173202 |
| 96 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.55067582 |
| 97 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.54603039 |
| 98 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.54029269 |
| 99 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.53897742 |
| 100 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.53844322 |
| 101 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.51708126 |
| 102 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.51370615 |
| 103 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.51070369 |
| 104 | * AMPK signaling pathway_Homo sapiens_hsa04152 | 0.49153529 |
| 105 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.48387126 |
| 106 | Peroxisome_Homo sapiens_hsa04146 | 0.48279261 |
| 107 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.47857289 |
| 108 | Mineral absorption_Homo sapiens_hsa04978 | 0.46198388 |
| 109 | * Insulin signaling pathway_Homo sapiens_hsa04910 | 0.45588337 |
| 110 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.45291287 |
| 111 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.44919837 |
| 112 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.44734718 |
| 113 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.44344460 |
| 114 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.44012320 |
| 115 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.43928688 |
| 116 | Lysine degradation_Homo sapiens_hsa00310 | 0.43750014 |
| 117 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.41777105 |
| 118 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.40671131 |
| 119 | Axon guidance_Homo sapiens_hsa04360 | 0.39108514 |
| 120 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.38344339 |
| 121 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.37697436 |
| 122 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.36091710 |
| 123 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.34535535 |
| 124 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.33374290 |
| 125 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.32687511 |
| 126 | * Insulin resistance_Homo sapiens_hsa04931 | 0.31810093 |
| 127 | * Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.31390533 |
| 128 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.28477910 |
| 129 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.27903944 |
| 130 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.27728080 |
| 131 | Glioma_Homo sapiens_hsa05214 | 0.26362398 |

